Integrative genome-scale metabolic analysis of Vibrio vulnificus for drug targeting and discovery

Molecular Systems Biology

Volumn 7, Issue , 2011, Pages

  Kim, Hyun Uk ^a   Kim, Soo Young ^b   Jeong, Haeyoung ^c   Kim, Tae Yong ^a   Kim, Jae Jong ^d   Choy, Hyon E ^e   Yi, Kyu Yang ^f   Rhee, Joon Haeng ^b,e   Lee, Sang Yup ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^b Chonnam National University   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^d GenoTech Corporation   (South Korea)

^e Chonnam National University Medical School   (South Korea)

^f Korea Research Institute of Chemical Technology   (South Korea)

Author keywords

drug discovery; drug targeting; genome analysis; metabolic network; Vibrio vulnificus

Indexed keywords

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL GENOME; CELL ASSAY; CELL SURVIVAL; CONTROLLED STUDY; DRUG DEVELOPMENT; DRUG TARGETING; GENE SEQUENCE; GENOME ANALYSIS; GENOMICS; METABOLISM; METABOLITE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIBRIO VULNIFICUS; BIOLOGICAL MODEL; CLUSTER ANALYSIS; DNA SEQUENCE; GENE REGULATORY NETWORK; GENETICS; METABOLOME; METABOLOMICS; METHODOLOGY; MOLECULAR GENETICS; PHYLOGENY; REPRODUCIBILITY; BACTERIAL METABOLISM; GENE INTERACTION;

VIBRIO VULNIFICUS;

CLUSTER ANALYSIS; DRUG DISCOVERY; GENE REGULATORY NETWORKS; GENOME, BACTERIAL; METABOLIC NETWORKS AND PATHWAYS; METABOLOME; METABOLOMICS; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; PHYLOGENY; REPRODUCIBILITY OF RESULTS; SEQUENCE ANALYSIS, DNA; VIBRIO VULNIFICUS;

ENZYME;

EID: 78751556862     PISSN: 17444292     EISSN: 17444292     Source Type: Journal    
DOI: 10.1038/msb.2010.115     Document Type: Article

References (77)

1. Allan JD, Moellering Jr RC (1985) Management of infections caused by gram-negative bacilli: the role of antimicrobial combinations. Rev Infect Dis 7 (Suppl 4): S559-S571
2. Aziz RK, Bartels D, Best AA, DeJongh M, Disz T, Edwards RA, Formsma K, Gerdes S, Glass EM, Kubal M, Meyer F, Olsen GJ, Olson R, Osterman AL, Overbeek RA, McNeil LK, Paarmann D, Paczian T, Parrello B, Pusch GD et al (2008) The RAST Server: rapid annotations using subsystems technology. BMC Genomics 9: 75
3. Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y, Baba M, Datsenko KA, Tomita M, Wanner BL, Mori H (2006) Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol 2: 2006.2008
4. Baker-Austin C, McArthur JV, Lindell AH, Wright MS, Tuckfield RC, Gooch J, Warner L, Oliver J, Stepanauskas R (2009) Multi-site analysis reveals widespread antibiotic resistance in the marine pathogen Vibrio vulnificus. Microb Ecol 57: 151-159
5. Berglez J, Pilling P, Macreadie I, Fernley RT (2005) Purification, properties, and crystallization of Saccharomyces cerevisiae dihydropterin pyrophosphokinase-dihydropteroate synthase. Protein Expr Purif 41: 355-362
6. Blaszczyk J, Li Y, Cherry S, Alexandratos J, Wu Y, Shaw G, Tropea JE, Waugh DS, Yan H, Ji X (2007) Structure and activity of Yersinia pestis 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase as a novel target for the development of antiplague therapeutics. Acta Crystallogr D Biol Crystallogr 63: 1169-1177
7. BoosW, Shuman H (1998) Maltose/maltodextrin system of Escherichia coli: transport, metabolism, and regulation. Microbiol Mol Biol Rev 62: 204-229
8. Bross MH, Soch K, Morales R, Mitchell RB (2007) Vibrio vulnificus infection: diagnosis and treatment. Am Fam Physician 76: 539-544
9. Caspi R, Foerster H, Fulcher CA, Kaipa P, Krummenacker M, Latendresse M, Paley S, Rhee SY, Shearer AG, Tissier C, Walk TC, Zhang P, Karp PD (2008) The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway/ genome databases. Nucleic Acids Res 36: D623-D631
10. Cirilli M, Zheng R, Scapin G, Blanchard JS (2003) The threedimensional structures of the Mycobacterium tuberculosis dihydrodipicolinate reductase-NADH-2,6-PDC and -NADPH-2,6- PDC complexes. Structural and mutagenic analysis of relaxed nucleotide specificity. Biochemistry 42: 10644-10650
11. CLSI (2006) Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard, 7th edn (M7- A7),Wayne, Pennsylvania, USA: Clinical and Laboratory Standards Institute
12. Derrick JP (2008) The structure and mechanism of 6-hydroxymethyl- 7,8-dihydropterin pyrophosphokinase. Vitam Horm 79: 411-433
13. Dobson PD, Patel Y, Kell DB (2009) 'Metabolite-likeness' as a criterion in the design and selection of pharmaceutical drug libraries. Drug Discov Today 14: 31-40
14. Droniuk R, Wong PT, Wisse G, Macleod RA (1987) Variation in quantitative requirements for Na for transport of metabolizable compounds by the marine bacteria Alteromonas haloplanktis 214 and Vibrio fischeri. Appl Environ Microbiol 53: 1487-1495
15. Duarte NC, Becker SA, Jamshidi N, Thiele I, Mo ML, Vo TD, Srivas R, Palsson BO (2007) Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc Natl Acad Sci USA 104: 1777-1782
16. Edwards JS, Palsson BO (2000) Robustness analysis of the Escherichia coli metabolic network. Biotechnol Prog 16: 927-939
17. Egan ES, Waldor MK (2003) Distinct replication requirements for the two Vibrio cholerae chromosomes. Cell 114: 521-530
18. El Zoeiby A, Sanschagrin F, Levesque RC (2003) Structure and function of the Mur enzymes: development of novel inhibitors. Mol Microbiol 47: 1-12
19. Fischbach MA, Walsh CT (2009) Antibiotics for emerging pathogens. Science 325: 1089-1093
20. Freiberg C, Brotz-Oesterhelt H, Labischinski H (2004) The impact of transcriptome and proteome analyses on antibiotic drug discovery. Curr Opin Microbiol 7: 451-459
21. Garrido-Franco M, Laber B, Huber R, Clausen T (2002) Enzyme-ligand complexes of pyridoxine 50-phosphate synthase: implications for substrate binding and catalysis. J Mol Biol 321: 601-612
22. Guimera R, Sales-Pardo M, Amaral LA (2007) A network-based method for target selection in metabolic networks. Bioinformatics 23: 1616-1622
23. Gulig PA, Bourdage KL, Starks AM (2005) Molecular pathogenesis of Vibrio vulnificus. J Microbiol 43: 118-131
24. Haft DH, Selengut JD, White O (2003) The TIGRFAMs database of protein families. Nucleic Acids Res 31: 371-373
25. Heidelberg JF, Eisen JA, Nelson WC, Clayton RA, Gwinn ML, Dodson RJ, Haft DH, Hickey EK, Peterson JD, Umayam L, Gill SR, Nelson KE, Read TD, Tettelin H, Richardson D, Ermolaeva MD, Vamathevan J, Bass S, Qin H, Dragoi I et al (2000) DNA sequence of both chromosomes of the cholera pathogen Vibrio cholerae. Nature 406: 477-483
26. Hlady WG, Klontz KC (1996) The epidemiology of Vibrio infections in Florida, 1981-1993. J Infect Dis 173: 1176-1183
27. Horton RM, Hunt HD, Ho SN, Pullen JK, Pease LR (1989) Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 77: 61-68
28. Hutton CA, Perugini MA, Gerrard JA (2007) Inhibition of lysine biosynthesis: an evolving antibiotic strategy. Mol Biosyst 3: 458-465
29. Jamshidi N, Palsson BO (2007) Investigating the metabolic capabilities of Mycobacterium tuberculosis H37Rv using the in silico strain iNJ661 and proposing alternative drug targets. BMC Syst Biol 1: 26
30. Jones MK, Oliver JD (2009) Vibrio vulnificus: disease and pathogenesis. Infect Immun 77: 1723-1733
31. Kanehisa M, Goto S, Hattori M, Aoki-Kinoshita KF, Itoh M, Kawashima S, Katayama T, Araki M, Hirakawa M (2006) From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res 34: D354-D357
32. Kim HJ, Lee JH, Rhee JE, Jeong HS, Choi HK, Chung HJ, Ryu S, Choi SH (2002) Identification and functional analysis of the putAP genes encoding Vibrio vulnificus proline dehydrogenase and proline permease. J Microbiol Biotechnol 12: 318-326
33. Kim HS, Lee MA, Chun SJ, Park SJ, Lee KH (2007a) Role of NtrC in biofilm formation via controlling expression of the gene encoding an ADP-glycero-manno-heptose-6-epimerase in the pathogenic bacterium, Vibrio vulnificus. Mol Microbiol 63: 559-574
34. Kim HU, Kim TY, Lee SY (2008) Metabolic flux analysis and metabolic engineering of microorganisms. Mol Biosyst 4: 113-120
35. Kim HU, Kim TY, Lee SY (2010a) Genome-scale metabolic network analysis and drug targeting of multi-drug resistant pathogen Acinetobacter baumannii AYE. Mol Biosyst 6: 339-348
36. Kim PJ, Lee DY, Kim TY, Lee KH, Jeong H, Lee SY, Park S (2007b) Metabolite essentiality elucidates robustness of Escherichia coli metabolism. Proc Natl Acad Sci USA 104: 13638-13642
37. Kim TY, Kim HU, Lee SY (2010b) Metabolite-centric approaches for the discovery of antibacterials using genome-scale metabolic networks. Metab Eng 12: 105-111
38. Kim TY, Kim HU, Park JM, Song H, Kim JS, Lee SY (2007c) Genomescale analysis of Mannheimia succiniciproducens metabolism. Biotechnol Bioeng 97: 657-671
39. Kim YR, Kim SY, Kim CM, Lee SE, Rhee JH (2005) Essential role of an adenylate cyclase in regulating Vibrio vulnificus virulence. FEMS Microbiol Lett 243: 497-503
40. Kim YR, Lee SE, Kim CM, Kim SY, Shin EK, Shin DH, Chung SS, Choy HE, Progulske-Fox A, Hillman JD, Handfield M, Rhee JH (2003) Characterization and pathogenic significance of Vibrio vulnificus antigens preferentially expressed in septicemic patients. Infect Immun 71: 5461-5471
41. Kitano H (2007) A robustness-based approach to systems-oriented drug design. Nat Rev Drug Discov 6: 202-210
42. Le Roux F, Zouine M, Chakroun N, Binesse J, Saulnier D, Bouchier C, Zidane N, Ma L, Rusniok C, Lajus A, Buchrieser C, Medigue C, Polz MF, Mazel D (2009) Genome sequence of Vibrio splendidus: an abundant planctonic marine species with a large genotypic diversity. Environ Microbiol 11: 1959-1970
43. Lee DS, Burd H, Liu J, Almaas E, Wiest O, Barabasi AL, Oltvai ZN, Kapatral V (2009) Comparative genome-scale metabolic reconstruction and flux balance analysis of multiple Staphylococcus aureus genomes identify novel antimicrobial drug targets. J Bacteriol 191: 4015-4024
44. Lee DY, Yun H, Park S, Lee SY (2003) MetaFluxNet: the management of metabolic reaction information and quantitative metabolic flux analysis. Bioinformatics 19: 2144-2146
45. Lee SE, KimSY, Kim CM, KimMK,KimYR, Jeong K, Ryu HJ, Lee YS, Chung SS, Choy HE, Rhee JH (2007) The pyrH gene of Vibrio vulnificus is an essential in vivo survival factor. Infect Immun 75: 2795-2801
46. Lim MS, Lee MH, Lee JH, Ju H-M, Park NY, Jeong HS, Rhee JE, Choi SH (2005) Identification and characterization of the Vibrio vulnificus malPQ operon. J Microbiol Biotechnol 15: 616-625
47. Liu YQ, Zhang YZ, Gao PJ (2004) Novel concentration-killing curve method for estimation of bactericidal potency of antibiotics in an in vitro dynamic model. Antimicrob Agents Chemother 48: 3884-3891
48. Lundqvist T, Fisher SL, Kern G, Folmer RH, Xue Y, Newton DT, Keating TA, Alm RA, de Jonge BL (2007) Exploitation of structural and regulatory diversity in glutamate racemases. Nature 447: 817-822
49. Ma H, Zeng AP (2003) Reconstruction of metabolic networks from genome data and analysis of their global structure for various organisms. Bioinformatics 19: 270-277
50. Makino K, Oshima K, Kurokawa K, Yokoyama K, Uda T, Tagomori K, Iijima Y, Najima M, Nakano M, Yamashita A, Kubota Y, Kimura S, Yasunaga T, Honda T, Shinagawa H, Hattori M, Iida T (2003) Genome sequence of Vibrio parahaemolyticus: a pathogenic mechanism distinct from that of V cholerae. Lancet 361: 743-749
51. Martinez JL, Baquero F (2000) Mutation frequencies and antibiotic resistance. Antimicrob Agents Chemother 44: 1771-1777
52. Mazumdar V, Snitkin ES, Amar S, Segre D (2009) Metabolic network model of a human oral pathogen. J Bacteriol 191: 74-90
53. Miller VL, Mekalanos JJ (1988) A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR. J Bacteriol 170: 2575-2583
54. Mills SD (2006) When will the genomics investment pay off for antibacterial discovery? Biochem Pharmacol 71: 1096-1102
55. Milton DL, O'Toole R, Horstedt P, Wolf-Watz H (1996) Flagellin A is essential for the virulence of Vibrio anguillarum. J Bacteriol 178: 1310-1319
56. Oberhardt MA, Puchalka J, Fryer KE, Martins dos Santos VA, Papin JA (2008) Genome-scale metabolic network analysis of the opportunistic pathogen Pseudomonas aeruginosa PAO1. J Bacteriol 190: 2790-2803
57. Park JM, Kim TY, Lee SY (2009) Constraints-based genome-scale metabolic simulation for systems metabolic engineering. Biotechnol Adv 27: 979-988
58. Park NY, Lee JH, Kim MW, Jeong HG, Lee BC, Kim TS, Choi SH (2006) Identification of the Vibrio vulnificus wbpP gene and evaluation of its role in virulence. Infect Immun 74: 721-728
59. Park SD, Shon HS, Joh NJ (1991) Vibrio vulnificus septicemia in Korea: clinical and epidemiologic findings in seventy patients. J Am Acad Dermatol 24: 397-403
60. Payne DJ, Gwynn MN, Holmes DJ, Pompliano DL (2007) Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat Rev Drug Discov 6: 29-40
61. Quirke AM, Reen FJ, Claesson MJ, Boyd EF (2006) Genomic island identification in Vibrio vulnificus reveals significant genome plasticity in this human pathogen. Bioinformatics 22: 905-910
62. Radu S, Elhadi N, Hassan Z, Rusul G, Lihan S, Fifadara N, Yuherman, Purwati E (1998) Characterization of Vibrio vulnificus isolated from cockles (Anadara granosa): antimicrobial resistance, plasmid profiles and random amplification of polymorphic DNA analysis. FEMS Microbiol Lett 165: 139-143
63. Reed JL, Vo TD, Schilling CH, Palsson BO (2003) An expanded genomescale model of Escherichia coli K-12 (iJR904 GSM/GPR). Genome Biol 4: R54
64. Ren Q, Paulsen IT (2005) Comparative analyses of fundamental differences in membrane transport capabilities in prokaryotes and eukaryotes. PLoS Comput Biol 1: e27
65. Rohdich F, Kis K, Bacher A, Eisenreich W (2001) The non-mevalonate pathway of isoprenoids: genes, enzymes and intermediates. Curr Opin Chem Biol 5: 535-540
66. Ruby EG, Urbanowski M, Campbell J, Dunn A, Faini M, Gunsalus R, Lostroh P, Lupp C, McCann J, Millikan D, Schaefer A, Stabb E, Stevens A, Visick K, Whistler C, Greenberg EP (2005) Complete genome sequence of Vibrio fischeri: a symbiotic bacterium with pathogenic congeners. Proc Natl Acad Sci USA 102: 3004-3009
67. Shen Y, Liu J, Estiu G, Isin B, Ahn YY, Lee DS, Barabasi AL, Kapatral V, Wiest O, Oltvai ZN (2010) Blueprint for antimicrobial hit discovery targeting metabolic networks. Proc Natl Acad Sci USA 107: 1082-1087
68. Silver LL (2007) Multi-targeting by monotherapeutic antibacterials. Nat Rev Drug Discov 6: 41-55
69. Strancar K, Boniface A, Blanot D, Gobec S (2007) Phosphinate inhibitors of UDP-N-acetylmuramoyl-L-alanyl-D-glutamate: L-lysine ligase (MurE). Arch Pharm (Weinheim) 340: 127-134
70. Tatusov RL, Fedorova ND, Jackson JD, Jacobs AR, Kiryutin B, Koonin EV, Krylov DM, Mazumder R, Mekhedov SL, Nikolskaya AN, Rao BS, Smirnov S, Sverdlov AV, Vasudevan S, Wolf YI, Yin JJ, Natale DA (2003) The COG database: an updated version includes eukaryotes. BMC Bioinformatics 4: 41
71. Thiele I, Palsson BO (2010) A protocol for generating a high-quality genome-scale metabolic reconstruction. Nat Protoc 5: 93-121
72. Thiele I, Vo TD, Price ND, Palsson BO (2005) Expanded metabolic reconstruction of Helicobacter pylori (iIT341 GSM/GPR): an in silico genome-scale characterization of single- and double-deletion mutants. J Bacteriol 187: 5818-5830
73. Valderas MW, Andi B, Barrow WW, Cook PF (2008) Examination of intrinsic sulfonamide resistance in Bacillus anthracis: a novel assay for dihydropteroate synthase. Biochim Biophys Acta 1780: 848-853
74. Vidaillac C, Leonard SN, Rybak MJ (2009) In vitro activity of ceftaroline against methicillin-resistant Staphylococcus aureus and heterogeneous vancomycin-intermediate S. aureus in a hollowfiber model. Antimicrob Agents Chemother 53: 4712-4717
75. Walsh C (2003) Where will new antibiotics come from? Nat Rev Microbiol 1: 65-70
76. Warner E, Oliver JD (2007) Refined medium for direct isolation of Vibrio vulnificus from oyster tissue and seawater. Appl Environ Microbiol 73: 3098-3100
77. Zander J, Besier S, Ackermann H, Wichelhaus TA (2010) Synergistic antimicrobial activities of folic acid antagonists and nucleoside analogs. Antimicrob Agents Chemother 54: 1226-1231